Dopamine Receptors

Dopamine receptor agonists and antagonists act on the five G protein-coupled receptors that respond to dopamine. The receptors form two groups, with D1 and D5 in the D1-like class and D2, D3 and D4 in the D2-like class. D1-like receptors stimulate adenylyl cyclase, whereas D2-like receptors inhibit it and lower cyclic adenosine monophosphate (cAMP) levels. Dopamine signaling controls movement, reward, motivation and hormone release, and is studied in Parkinson's disease and psychiatric research. Ligands here include the agonist rotigotine HCl, the D2 antagonists L-741626 and domperidone, and the D3-preferring ligand BP897.

Items 126-150 of 170

  • Onzigolide
    Cat. No.
    A60120

    Onzigolide

    Synonyms: BIM-23A760; TBR-760

    Onzigolide is a chimeric compound that acts as a potent agonist at dopamine type 2 (D2R) and somatostatin type 2 (SSTR2) receptors. This dual receptor activation may play a crucial role in modulating neuroendocrine and neurological functions. It is particularly relevant in research focused on neuropsychiatric disorders and endocrine-related conditions, contributing to the understanding of receptor interactions and their implications in therapeutic contexts.

    5 mg
    $795.00
    All 1 sizes
  • (-)-IHCH7041
    Cat. No.
    A60123

    (-)-IHCH7041

    (-)-IHCH7041 is a selective and orally active agonist of the dopamine D2 receptor, exhibiting a Ki value of 22.44 nM. It effectively activates the Gαi1 protein and β-arrestin2 signaling pathways with EC50 values of 1.38 nM and 2.75 nM, respectively. This compound has demonstrated potential in enhancing cognitive function and memory capacity, making it valuable for research into neurological disorders, including Alzheimer's disease.

    25 mg
    $1,530.00
    50 mg
    $1,950.00
    All 3 sizes
  • Adrogolide
    Cat. No.
    A60124

    Adrogolide

    Synonyms: ABT-431; DAS-431

    Adrogolide is a prodrug of A-86929, functioning as a selective agonist of the dopamine D1 receptor. Upon administration, Adrogolide is rapidly converted to A-86929 in the plasma, enhancing locomotor activity and improving behavioral outcomes. Additionally, it has been shown to reduce cocaine-seeking behavior, making it a valuable compound for research into the mechanisms underlying Parkinson's disease and addiction-related behaviors.

    Out of stock

    All 3 sizes
  • SKF 38393 hydrobromide
    Cat. No.
    A60125

    SKF 38393 hydrobromide

    Synonyms: (±)-SKF-38393 hydrobromide

    SKF 38393 hydrobromide is a selective agonist of the dopamine D1 receptor (D1DR), exhibiting a binding affinity characterized by an IC50 value of 110 nM. This compound is widely utilized in research to investigate the role of D1 receptors in various neurological processes, including cognition and motor control. Its specificity for D1DR makes it valuable for studies focused on dopaminergic signaling pathways and related diseases.

    1 mg
    $35.00
    5 mg
    $45.00
    All 7 sizes
  • RU-24213 hydrochloride
    Cat. No.
    A60126

    RU-24213 hydrochloride

    RU-24213 hydrochloride is a selective agonist for the D-2 dopamine receptor, known to modulate dopaminergic signaling. Additionally, it acts as an antagonist at the kappa-opioid receptor, contributing to its pharmacological profile. This compound has been observed to induce stereotyped behaviors, making it valuable for research in neuropharmacology and the exploration of dopamine-related conditions.

    Out of stock

    All 3 sizes
  • Quinagolide
    Cat. No.
    A60127

    Quinagolide

    Synonyms: CV205-502

    Quinagolide is a non-ergot dopamine D(2) receptor agonist that enhances dopamine activity. It is primarily utilized in the modulation of endocrine function, particularly in the suppression of hyperprolactinemia and its associated clinical symptoms. Quinagolide's significant biological activity makes it a valuable reagent for research in endocrine disorders and drug development, facilitating the study of dopamine's role in various physiological processes.

    25 mg
    $2,160.00
    50 mg
    $2,770.00
    All 3 sizes
  • A-77636
    Cat. No.
    A60129

    A-77636

    A-77636 is a potent and selective orally active agonist of the dopamine D1 receptor, demonstrating a pEC50 of 8.13 and an EC50 of 1.1 nM. It exhibits a high affinity for the dopamine D1 receptor with a pKi value of 7.40 ± 0.09 (Ki = 39.8 nM). Due to its pharmacological profile, A-77636 is primarily utilized in research related to Parkinson's disease and other dopamine-related disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • UNC9975
    Cat. No.
    A60131

    UNC9975

    UNC9975 is a D2 receptor (D2R) agonist that demonstrates signaling bias through β-arrestin-mediated pathways while also acting as an antagonist of Gi-regulated cAMP production and a partial agonist for D2R/β-arrestin-2 interactions. This compound is valuable for research in antipsychotic drug development, facilitating the exploration of novel therapeutic approaches targeting dopaminergic signaling.

    1 mg
    $235.00
    5 mg
    $590.00
    All 5 sizes
  • Noncatechol agonist-1
    Cat. No.
    A60132

    Noncatechol agonist-1

    Noncatechol agonist-1 is a potent noncatechol agonist primarily targeting the dopamine D1 receptor (D1R). It demonstrates full efficacy in activating both the D1R-G protein and D1R-β-arrestin2 pathways, with pEC50 values of 8.41 for D1R-mediated cAMP production and 7.7 for β-arrestin2 recruitment. This compound is valuable for research applications investigating dopamine signaling and its implications in neurobiology and pharmacology.

    1 mg
    $535.00
    5 mg
    $1,650.00
    All 3 sizes
  • Zelandopam free base
    Cat. No.
    A60133

    Zelandopam free base

    Synonyms: YM435 free base

    Zelandopam free base is a specific agonist of the dopamine D1 receptor, demonstrating notable renal vasodilatory effects. This compound is effective in mitigating acute renal failure induced by Cisplatin, making it a valuable tool for research investigating renal protection and dopamine receptor signaling. Its oral bioactivity further enhances its utility in pharmacological studies related to renal function and neurotransmitter interactions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • SKF 38393
    Cat. No.
    A60134

    SKF 38393

    SKF 38393 is a selective agonist of the dopamine D1 receptor that activates the cAMP signaling pathway, enhancing dopamine release in the developing rat striatum. This compound has been shown to inhibit the proliferation of MCF-7 breast cancer cells with an IC50 of 0.1 μM. SKF 38393 is instrumental in research focused on neurodevelopmental disorders, dopamine-related diseases such as Parkinson's, and cancer biology.

    Out of stock

    All 3 sizes
  • 7-Hydroxy-DPAT
    Cat. No.
    A60135

    7-Hydroxy-DPAT

    Synonyms: 7-OH-DPAT

    7-Hydroxy-DPAT is a selective agonist of the D3 dopamine receptor, known for its ability to modulate locomotor behavior and influence dopamine metabolism in the brain. This compound demonstrates significant pharmacological activity that can be utilized in research focused on neurological diseases and disorders. Its selectivity for the D3 receptor makes it a valuable tool for studies investigating dopamine-related pathways and their implications in various neurological conditions.

    Out of stock

    All 3 sizes
  • OS-3-106
    Cat. No.
    A60136

    OS-3-106

    OS-3-106 is a potent and selective agonist of the dopamine D3 receptor (D3R), demonstrating a high binding affinity with a Ki value of 0.2 nM. This compound serves as a valuable tool in the study of D3R-mediated pathways, particularly in the context of psychoactive substance addiction research. Its specificity and efficacy make it suitable for exploring mechanisms underlying dopamine signaling and addiction-related behaviors.

    5 mg
    $20.00
    10 mg
    $25.00
    All 5 sizes
  • SKF83822 hydrobromide
    Cat. No.
    A60138

    SKF83822 hydrobromide

    SKF83822 hydrobromide is a potent agonist of the dopamine D1 receptor, primarily engaging Gs/olf signaling pathways to activate adenylyl cyclase. It is effective in stimulating intracellular cAMP production, making it a valuable tool for research in neuropharmacology and the study of dopamine-related disorders. Its selectivity for D1 receptors over PLC-coupled D1-like receptors underscores its utility in elucidating D1-mediated signaling processes.

    50 mg
    $3,200.00
    All 1 sizes
  • PF-00217830
    Cat. No.
    A60139

    PF-00217830

    PF-00217830 is a selective agonist of the dopamine D2 receptor, demonstrating substantial efficacy in modulating dopaminergic signaling. It has been shown to inhibit spontaneous locomotor activity as well as reduce 2,5-dimethoxy-4-iodoamphetamine-induced head twitches in rodent models. This compound is valuable for studying the role of dopamine in neuropharmacology and assessing potential therapeutic strategies for disorders associated with dopamine dysregulation.

    1 mg
    $70.00
    5 mg
    $175.00
    All 7 sizes
  • LY 171859
    Cat. No.
    A60144

    LY 171859

    LY 171859 is a selective D2 receptor agonist that also displays notable reductase activity. This compound demonstrates enzymatic function within the cytoplasm of various tissues, including liver, lung, and kidney, and exhibits significant reductase activity in both rat and human blood. The reduction process mediated by LY 171859 is NADPH-dependent, with an apparent Km of 14.8 μM, and specifically incorporates the A-side hydrogen of NADPH into the reaction product. Additionally, this compound's enzymatic activity is sensitive to inhibition by cyanide and thiol reagents, making it a useful tool for studying dopamine receptor signaling and associated metabolic pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MOR agonist-2
    Cat. No.
    A60145

    MOR agonist-2

    MOR agonist-2 is a potent agonist of the mu-opioid receptor (MOR) with a Ki value of 564 nM, and it acts as an antagonist at the dopamine D3 receptor (D3R) with a Ki of 7.26 nM. This compound exhibits analgesic properties through its partial agonism at MOR, making it a valuable tool for research in pain management. Additionally, its D3R antagonism may help mitigate opioid misuse liability, offering potential therapeutic benefits in addiction studies.

    Out of stock

    All 3 sizes
  • Zelandopam anhydrous
    Cat. No.
    A60148

    Zelandopam anhydrous

    Synonyms: YM435 anhydrous

    Zelandopam anhydrous is a selective agonist of the dopamine D1 receptor, exhibiting potent renal vasodilatory effects. This compound demonstrates significant potential in alleviating acute renal failure induced by Cisplatin. It is valuable for research in nephrology and may aid in exploring therapeutic approaches for renal pathologies.

    25 mg
    $1,275.00
    All 1 sizes
  • rel-Quinpirole dihydrochloride
    Cat. No.
    A60151

    rel-Quinpirole dihydrochloride

    Synonyms: rel-LY 171555 dihydrochloride; rel-LY 141865 dihydrochloride

    rel-Quinpirole dihydrochloride is a selective dopamine D2 receptor agonist that acts primarily on the D2R target. This compound exhibits significant biological activity in modulating dopamine signaling pathways and is utilized in research applications related to neurological diseases, including Parkinson's disease and schizophrenia. Its use can facilitate the investigation of dopaminergic functions and the development of potential therapeutic strategies.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes
  • Lergotrile
    Cat. No.
    A60153

    Lergotrile

    Lergotrile is a potent, orally active dopamine agonist that functions primarily as a prolactin secretion inhibitor. It exerts its biological activity by activating adenohypophyseal dopamine receptors, leading to the inhibition of prolactin release from the pituitary gland. This compound holds potential for research applications related to Parkinson's disease and other dopaminergic disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Piribedil N-oxide
    Cat. No.
    A60162

    Piribedil N-oxide

    Piribedil N-oxide is a metabolite of the dopamine receptor agonist Piribedil, primarily functioning as a drug metabolite. This compound retains the ability to interact with dopamine receptors, contributing to studies on dopamine signaling pathways and pharmacokinetics. Its characterization is essential for understanding the metabolic fate of Piribedil and its potential implications in neurological research and therapeutic applications.

    1 mg
    $25.00
    5 mg
    $90.00
    All 6 sizes
  • ABT-724
    Cat. No.
    A60163

    ABT-724

    ABT-724 is a potent and highly selective agonist of the dopamine D4 receptor, exhibiting an EC50 of 12.4 nM for the human receptor. It also demonstrates efficacy as a partial agonist at the rat and ferret D4 receptors, with EC50 values of 14.3 nM and 23.2 nM, respectively. ABT-724 shows minimal activity against dopamine D1, D2, D3, and D5 receptors, making it a valuable tool for exploring the role of the D4 receptor in neurological conditions and potential therapeutic applications for erectile dysfunction.

    5 mg
    $25.00
    10 mg
    $50.00
    All 5 sizes
  • Quinelorane
    Cat. No.
    A60165

    Quinelorane

    Synonyms: LY163502 free base

    Quinelorane is a potent dopamine D2 receptor agonist. It has been shown to facilitate semen ejaculation while inhibiting penile erection in rat models. This compound is valuable for investigating mechanisms underlying sexual dysfunction and related therapeutic approaches.

    Out of stock

    All 3 sizes
  • PF 219061
    Cat. No.
    A60173

    PF 219061

    PF 219061 is a selective agonist of the dopamine D3 receptor, exhibiting an EC50 of 15 nM. This compound demonstrates rapid absorption and efficient liver blood clearance, making it suitable for studying female sexual dysfunction. Its specificity for the D3 receptor allows for exploration of its potential therapeutic applications in related disorders.

    Out of stock

    All 3 sizes
  • A-412997
    Cat. No.
    A60176

    A-412997

    A-412997 is a selective agonist of the Dopamine D4 receptor, exhibiting Ki values of 12 nM for rat and 7.9 nM for human receptors. This compound has been demonstrated to enhance short-term memory and cognitive functions in rodent models, making it a valuable tool for research into psychiatric disorders and cognitive enhancement. Its specificity and potency facilitate studies on the Dopamine D4 receptor's role in neurobiology and medicine.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes

Items 126-150 of 170

Added to your cart

View Cart Checkout

    Loading...